Krystal Biotech Inc (KRYS)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 179,669 | 143,204 | 72,935 | 4,373 | -40,772 | -86,899 | -91,693 | -83,652 | -75,835 | -65,603 | -55,240 | -47,176 | -40,433 | -32,938 | -27,946 | -21,462 | -13,729 | -12,186 | -9,063 | -7,422 |
| Revenue (ttm) | US$ in thousands | 293,354 | 247,796 | 172,511 | 103,808 | 58,154 | 10,946 | 2,390 | 809 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 542 |
| Gross profit margin | 61.25% | 57.79% | 42.28% | 4.21% | -70.11% | -793.89% | -3,836.53% | -10,340.17% | — | — | — | — | — | — | — | — | — | — | — | -1,369.37% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $179,669K ÷ $293,354K
= 61.25%
The gross profit margin of Krystal Biotech Inc has shown significant fluctuations over the reported periods. Starting with a negative margin of -1,369.37% on March 31, 2020, the company's gross profit margin remained negative or not reported until December 31, 2023. However, there was a notable improvement in the performance as of March 31, 2024, with a positive gross profit margin of 4.21%. The trend continued to strengthen, reaching 61.25% by December 31, 2024.
This improvement indicates that the company was able to enhance its revenue generation relative to the cost of goods sold during the latter part of the reporting period. Such a positive trend in the gross profit margin suggests that Krystal Biotech Inc has potentially made effective operational adjustments or strategic decisions, contributing to enhanced profitability and financial performance.
Peer comparison
Dec 31, 2024